The (cid:1) 256T (cid:2) C Polymorphism in the Apolipoprotein A-II Gene Promoter Is Associated with Body Mass Index and Food Intake in the Genetics of Lipid Lowering Drugs and Diet Network Study
暂无分享,去创建一个
I. Borecki | Michael Province | D. Corella | D. Arnett | R. Straka | J. Ordovás | J. Hixson | E. Kabagambe | L. Parnell | Chao-Qiang Lai | M. Tsai | J. M. Peacock | M. Province
[1] Melinda E. Lull,et al. Apo-AII is an elevated biomarker of chronic non-human primate ethanol self-administration. , 2006, Alcohol and alcoholism.
[2] Claude Bouchard,et al. The Human Obesity Gene Map: The 2005 Update , 2006, Obesity.
[3] N. Cook,et al. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. , 2005, JAMA.
[4] Jan Karlsson,et al. Genetic and environmental influences on eating behavior: the Swedish Young Male Twins Study. , 2005, The American journal of clinical nutrition.
[5] J. Lovejoy,et al. Apolipoprotein A-II polymorphism and visceral adiposity in African-American and white women. , 2005, Obesity research.
[6] William E Grizzle,et al. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] Frédéric Fumeron,et al. Polymorphism of the 5-HT2A receptor gene and food intakes in children and adolescents: the Stanislas Family Study. , 2005, The American journal of clinical nutrition.
[8] R. Jandacek,et al. Diurnal changes in intestinal apolipoprotein A-IV and its relation to food intake and corticosterone in rats. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[9] Alberto Riva,et al. MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes , 2005, BMC Bioinformatics.
[10] P. Tso,et al. Apolipoprotein A-IV, food intake, and obesity , 2004, Physiology & Behavior.
[11] D. Arnett,et al. Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load. , 2004, Clinical chemistry.
[12] F. Blanco-Vaca,et al. Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility , 2004, Current opinion in lipidology.
[13] C. Bouchard,et al. A genome-wide linkage scan for dietary energy and nutrient intakes: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study. , 2004, The American journal of clinical nutrition.
[14] C. Shelley,et al. A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia , 1986, Human Genetics.
[15] J. Chambaz,et al. Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance , 2003, Current opinion in lipidology.
[16] M. Emi,et al. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred , 2002, Journal of Human Genetics.
[17] E. Boerwinkle,et al. Sequence polymorphism at the human apolipoprotein AII gene (APOA2): unexpected deficit of variation in an African-American sample , 2002, Human Genetics.
[18] J. Fruchart,et al. Apolipoprotein A-II, HDL metabolism and atherosclerosis. , 2002, Atherosclerosis.
[19] J. Jobe,et al. Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study. , 2002, Journal of the American Dietetic Association.
[20] J. Otvos,et al. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. , 2002, Clinical laboratory.
[21] D. Midthune,et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study. , 2001, American journal of epidemiology.
[22] F. Blanco-Vaca,et al. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. , 2001, Journal of lipid research.
[23] A. Hamsten,et al. Human Evidence That the Apolipoprotein A-II Gene Is Implicated in Visceral Fat Accumulation and Metabolism of Triglyceride-Rich Lipoproteins , 2001, Circulation.
[24] A. Lusis,et al. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. , 2001, Diabetes.
[25] G. Siest,et al. Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake , 2001, Molecular Psychiatry.
[26] G. Luc,et al. Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[27] G Siest,et al. 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people , 2000, International Journal of Obesity.
[28] T. Bouchard,et al. Genetic and environmental influences on self-reported diet: a reared-apart twin study , 1998, Physiology & Behavior.
[29] J. Ordóñez‐Llanos,et al. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet. , 1998, Journal of lipid research.
[30] A. Lusis,et al. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. , 1997, The Journal of clinical investigation.
[31] C. Bouchard,et al. The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity. , 1997, Atherosclerosis.
[32] D C Rao,et al. NHLBI Family Heart Study: objectives and design. , 1996, American journal of epidemiology.
[33] A. Lusis,et al. Apolipoprotein A-II: a protein in search of a function. , 1994, The Canadian journal of cardiology.
[34] A. Daluiski,et al. Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. K. Dunn,et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[36] E. Rubin,et al. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. , 1992, The Journal of biological chemistry.
[37] J. Cardelli,et al. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. , 1992, The American journal of physiology.
[38] J. Buring,et al. Decreased HDL2 and HDL3 Cholesterol, Apo A‐I and Apo A‐II, and Increased Risk of Myocardial Infarction , 1992, Circulation.
[39] J. Scott,et al. HIGH-DENSITY LIPOPROTEIN COMPOSITION IS ALTERED BY A COMMON DNA POLYMORPHISM ADJACENT TO APOPROTEIN AII GENE IN MAN , 1985, The Lancet.
[40] L Wilhelmsen,et al. Multivariate Analyses of Serum Apolipoproteins and Risk Factors in Relation to Acute Myocardial Infarction , 1981, Arteriosclerosis.